ScholarIQanswers from OpenAlex

Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety

PaperCitations, authors & open-access status

Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety have?

ScholarIQcitation count

Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety has 9 citations in the OpenAlex counts ScholarIQ stores.

When was Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety published?

ScholarIQyear

Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety has 2025 year in the ScholarIQ index.

What is the open-access status of Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety?

ScholarIQoa status

Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety has gold oa status in the ScholarIQ index.

What is the DOI of Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety?

ScholarIQdoi

The DOI for Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety is on the source record.

What is the PMID of Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety?

ScholarIQpmid

The PMID for Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety is on the source record.

What is the OpenAlex record for Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety?

ScholarIQopenalex

The OpenAlex for Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial